Trial Profile
feasibility study on CPT-11/TS-1 sequential therapy for TS-1-resistant unresectable gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 05 Sep 2011 New trial record